These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32196069)

  • 1. The multiple roles of chemokines in the mechanisms of stent biocompatibility.
    Ravindran D; Karimi Galougahi K; Tan JTM; Kavurma MM; Bursill CA
    Cardiovasc Res; 2021 Sep; 117(11):2299-2308. PubMed ID: 32196069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Density Lipoproteins and Apolipoprotein A-I Improve Stent Biocompatibility.
    Vanags LZ; Wong NKP; Nicholls SJ; Bursill CA
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1691-1701. PubMed ID: 29954755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.
    Borovac JA; D'Amario D; Vergallo R; Porto I; Bisignani A; Galli M; Annibali G; Montone RA; Leone AM; Niccoli G; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):105-116. PubMed ID: 30285099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation.
    Zhang DM; Chen SL
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):388-393. PubMed ID: 34029271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Stent Atherosclerosis at a Crossroads: Neoatherosclerosis … or Paleoatherosclerosis?
    Andreou I; Stone PH
    Circulation; 2016 Nov; 134(19):1413-1415. PubMed ID: 27821417
    [No Abstract]   [Full Text] [Related]  

  • 6. Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.
    Lehtinen T; Airaksinen KE; Ylitalo A; Karjalainen PP
    Int J Cardiovasc Imaging; 2012 Dec; 28(8):1859-66. PubMed ID: 22362097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INtimal hyPerplasia evAluated by oCT in de novo COROnary lesions treated by drug-eluting balloon and bare-metal stent (IN-PACT CORO): study protocol for a randomized controlled trial.
    Burzotta F; Brancati MF; Trani C; Porto I; Tommasino A; De Maria G; Niccoli G; Leone AM; Coluccia V; Schiavoni G; Crea F
    Trials; 2012 May; 13():55. PubMed ID: 22559260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
    EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
    Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
    Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
    Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
    Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of neointimal coverage between durable-polymer everolimus-eluting stents and bioresorbable-polymer everolimus-eluting stents 1 year after implantation using high-resolution coronary angioscopy.
    Nojima Y; Adachi H; Ihara M; Kurimoto T; Okayama K; Sakata Y; Nanto S
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):204-209. PubMed ID: 30737973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.